This mechanism could play a role in the development of DILI in individuals taking medications that produce drug-related neoantigens, triggering immune-mediated hepatic injury and compromising liver function [57] (Table 3)
Structurally, it consists of a precise sequence of five amino acids, engineered to interact with the growth hormone secretagogue receptor (GHS-R1a)
Monitor renal function in patients reporting adverse reactions to Victoza that could lead to volume depletion, especially during dosage initiation and escalation of Victoza Severe Gastrointestinal Adverse Reactions: Use of GLP-1 receptor agonists, including Victoza , has been associated with gastrointestinal adverse reactions, sometimes severe
CrossRef Multi-omics reveals the associations among the fecal metabolome, intestinal bacteria, and serum indicators in patients with hepatocellular carcinoma Jing Feng, Jun-Ping Wang, Jian-Ran Hu, Ping Li, Pin Lv, Hu-Cheng He, Xiao-Wei Cheng, Zheng Cao, Jia-Jing Han, Qiang Wang, Qian Su, Li-Xin Liu World Journal of Gastroenterology .2025;[Epub] CrossRef The crosstalk between gut microbiota and microbiota-derived metabolites in hepatocellular carcinoma Sang Jun Yoon, Seul Ki Han, Tae Suk Kim, Ki Tae Suk, Dae Hee Choi, Young Don Kim, Moon Young Kim, Gab Jin Cheon, Soon Koo Baik, Dong Joon Kim Critical Reviews in Microbiology .2025
Brighten: What have you found in the research and in your clinical experience that These medications are doing outside of just the weight loss conversation